The EU Commission conditionally clears a merger between two pharmaceutical companies (Teva / Ratiopharm)

"Mergers: main developments between 1 May and 31 August 2010"* On 3 August the Commission approved the proposed acquisition of the German generic pharmaceutical company Ratiopharm by Teva, Israel. The decision is conditional upon the divestment of 15 products in the Netherlands and one in Hungary. The Commission had concerns that the parties’ high combined market shares for these

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • JG Associates (Brussels)

Quotation

John Gatti, The EU Commission conditionally clears a merger between two pharmaceutical companies (Teva / Ratiopharm), 3 August 2010, e-Competitions August 2010, Art. N° 37416

Visites 450

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues